Local News

New Genomic Regions Linked to Common Vascular Disorder

By November 6, 2019No Comments

Blood clotting in veins, a disorder called venous thromboembolism (VTE), is a common vascular disease like heart attack and stroke, but hasn’t been as well studied. Genetics are known to be involved, but only about a dozen genomic regions have been linked with the condition. Now a large genetic study of VTE led by researchers at the Broad Institute of MIT and Harvard, Massachusetts General Hospital (MGH), and the US Department of Veterans Affairs (VA) Boston Healthcare System has found 22 new regions in the genome that contribute to the disease. The team has also developed a genetic score that could one day be used to identify patients at highest risk for the disease.

A more accurate way of predicting who’s at increased risk could better ensure that only the highest risk patients receive preventative treatment for VTE, namely blood-thinning drugs, which can predispose patients to excessive bleeding.

The study, published in the November 2019 issue of Nature Genetics, analyzed genetic data from more than 650,000 people and found 33 locations in the genome — 22 not previously known —  that may play a role in the disease. The team also revealed some genetic overlap with other forms of vascular disease, an insight that could help spark the development of new, safer treatments.

“Our study represents a significant step forward in genetic discovery for VTE, both in terms of the number and diversity of individuals we studied as well as the number of genetic variants we identified that were linked to VTE,” said senior author Pradeep Natarajan, an associate member at the Broad Institute and director of preventive cardiology at MGH.